The UK drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). One of the major factors that [propels the market growth in the country includes significant growth in R&D investment in the pharmaceutical sector. According to the Association of the British Pharmaceutical Industry (ABPI), UK pharmaceutical industry is significantly investing in R&D. The country invested nearly $6.4 billion in 2017. The rising investment in the pharmaceutical sector increases the adoption of advanced analytics solutions for drug discovery as the application of analytics facilitates a cost-effective, innovative, and streamlined R&D process in the pharmaceutical industry.
To Request a Sample of our Report on UK Drug Discovery Informatics Market: https://www.omrglobal.com/request-sample/uk-drug-discovery-informatics-market
Some of the major research institutes working in the area of synthetic biology in the country include the University of Cambridge, University of Edinburgh, The UK’s national industrial center for synthetic biology, and so on. The University of Edinburgh has the UK Centre for Mammalian Synthetic Biology Research. It is working in the field of whole-cell modeling, cell engineering tool generation, high-throughput phenotyping, and CAD & assembly of DNA. Whole-cell modeling has an essential role in drug testing industries, diagnostics, novel therapeutics, protein-based drugs, and regenerative medicine. Therefore, the significant trend towards synthetic biology further increases the demand for analytics tools for drug discovery in the country.
(Get 15% Discount on Buying this Report)
A full Report of UK Drug Discovery Informatics Market is Available at: https://www.omrglobal.com/industry-reports/uk-drug-discovery-informatics-market
By Function
- Docking
- Molecular Modeling
- Libraries and Database Preparation
- Sequencing and Target Data Analysis
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CRO)
Others (Research Institutes)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
